within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L04A_Immunosuppressants.L04AX07_DimethylFumarate;

model DimethylFumarate
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.27,
    Cl = 2.6666666666666667e-05,
    adminDuration = 600,
    adminMass = 240 / 1000000,
    adminCount = 1,
    Vd = 0.053,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.0055000000000000005,
    Tlag = 600);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>DimethylFumarate</td></tr><tr><td>ATC code:</td><td>L04AX07</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>240</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>53</td><td>L</td></tr>
    <tr><td>clearance:</td><td>96</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Dimethyl fumarate is an oral immunomodulatory drug approved for the treatment of relapsing-remitting multiple sclerosis (RRMS) and also used in the management of moderate to severe plaque psoriasis. It acts by activating the Nrf2 pathway and reducing oxidative stress and inflammation.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are reported for healthy adult volunteers and patients with relapsing-remitting multiple sclerosis (RRMS), following oral administration.</p><h4>References</h4><ol><li><p>Hosseini, A, et al., &amp; Jadidi-Niaragh, F (2019). Dimethyl fumarate: Regulatory effects on the immune system in the treatment of multiple sclerosis. <i>Journal of cellular physiology</i> 234(7) 9943–9955. DOI:<a href=\"https://doi.org/10.1002/jcp.27930\">10.1002/jcp.27930</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30536402/\">https://pubmed.ncbi.nlm.nih.gov/30536402</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.L.L04AX07 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end DimethylFumarate;
